Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ACE-041

Known as: ALK1-Fc Fusion Protein ACE-041, Activin Receptor-like Kinase 1 Inhibitor ACE-041 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Development of anti-angiogenic therapy including the vascular endothelial growth factor (VEGF) antibodies and VEGF-tyrosine… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
2013
2013
Purpose: The angiogenesis inhibitor dalantercept (formerly ACE-041) is a soluble form of activin receptor–like kinase-1 (ALK1… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
30 Background: Activin receptor-like kinase 1 (ALK1) is a type 1 receptor in the TGF-β superfamily. The ALK1 pathway plays a role… Expand
Is this relevant?
2012
2012
Treatment of metastatic RCC with agents that block signaling through VEGFR2 induces disease stabilization or regression in a… Expand
Is this relevant?
2011
2011
3070 Background: Activin receptor-like kinase-1 (ALK1) is a type I receptor in the TGFß superfamily expressed on endothelial… Expand
Is this relevant?
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Background: Activin receptor-like kinase-1 (ALK1) is a… Expand
Is this relevant?